METHYLDOPA - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for methyldopa and what is the scope of patent protection?

Methyldopa is the generic ingredient in three branded drugs marketed by Merck, Accord Hlthcare, Chartwell Rx, Duramed Pharms Barr, Halsey, Heritage Pharma, Parke Davis, Pliva, Purepac Pharm, Rising, Roxane, Strides Pharma, Sun Pharm Industries, Superpharm, Teva, Watson Labs, Abraxis Pharm, Am Regent, Baxter Hlthcare, Hospira, Marsam Pharms Llc, Smith And Nephew, and Teva Parenteral, and is included in fifty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for methyldopa. Two suppliers are listed for this compound.

Sponsor	Phase
Cairo University	Phase 4
Federal University of Paraíba	Phase 4
Assiut University	Phase 2

Sponsor

Phase

Cairo University

Phase 4

Federal University of Paraíba

Phase 4

Assiut University

Phase 2

US Patents and Regulatory Information for METHYLDOPA

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare	METHYLDOPATE HYDROCHLORIDE	methyldopate hydrochloride	INJECTABLE;INJECTION	070291-001	Jul 1, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Rising	METHYLDOPA	methyldopa	TABLET;ORAL	070076-002	Apr 18, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Parke Davis	METHYLDOPA	methyldopa	TABLET;ORAL	070333-001	Apr 15, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	METHYLDOPA	methyldopa	TABLET;ORAL	070703-001	Jun 6, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Accord Hlthcare	METHYLDOPA	methyldopa	TABLET;ORAL	070085-001	Oct 15, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Heritage Pharma	METHYLDOPA	methyldopa	TABLET;ORAL	070343-001	Feb 20, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Merck	ALDOMET	methyldopa	SUSPENSION;ORAL	018389-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicant

Tradename

Generic Name

Dosage

NDA

Approval Date

Patent No.

Patent Expiration

SUSPENSION;ORAL

Approved Prior to Jan 1, 1982

⤷ Sign Up

>Applicant

>Tradename

>Generic Name

>Dosage

>NDA

>Approval Date

>Patent No.

>Patent Expiration

Subscribe to access the full database, or Sign Up

US Patents:	0
Tradenames:	3
Applicants:	23
NDAs:	57
Drug Master File Entries:	19
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	96
Clinical Trials:	19
Patent Applications:	5,656
Drug Prices:	Drug price trends for METHYLDOPA
What excipients (inactive ingredients) are in METHYLDOPA?	METHYLDOPA excipients list
DailyMed Link:	METHYLDOPA at DailyMed

Drug Class	Central alpha-2 Adrenergic Agonist
Mechanism of Action	Adrenergic alpha2-Agonists

METHYLDOPA - Generic Drug Details

What are the generic sources for methyldopa and what is the scope of patent protection?

Summary for METHYLDOPA

Recent Clinical Trials for METHYLDOPA

Pharmacology for METHYLDOPA

Medical Subject Heading (MeSH) Categories for METHYLDOPA

US Patents and Regulatory Information for METHYLDOPA

Expired US Patents for METHYLDOPA

Make Better Decisions: Try a trial or see plans & pricing